APA (7th ed.) Citation

R, K., ET, H., K, D., O, B., F, H., O, D., . . . F, K. (2024). The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation. Cell, 187(16), 4318. https://doi.org/10.1016/j.cell.2024.06.014

Chicago Style (17th ed.) Citation

R, Knoll, et al. "The Life-saving Benefit of Dexamethasone in Severe COVID-19 Is Linked to a Reversal of Monocyte Dysregulation." Cell 187, no. 16 (2024): 4318. https://doi.org/10.1016/j.cell.2024.06.014.

MLA (9th ed.) Citation

R, Knoll, et al. "The Life-saving Benefit of Dexamethasone in Severe COVID-19 Is Linked to a Reversal of Monocyte Dysregulation." Cell, vol. 187, no. 16, 2024, p. 4318, https://doi.org/10.1016/j.cell.2024.06.014.